I-Liposomal NAD+ Isekela Kanjani Ukukhiqizwa Kwe-ATP, Ukulungiswa Kwe-DNA Nokuguga Okunempilo

Kososayensi bokwakha, abaqondisi be-R&D, nabanikazi bomkhiqizo abakha imikhiqizo{0}}yesizukulwane esilandelayo yokuphila isikhathi eside, ukuqonda izindlela zamaselulaliposomal NAD+kubalulekile ekukhetheni isithako unolwazi kanye nokuma komkhiqizo. I-NAD+ (i-nicotinamide adenine dinucleotide) iyi-metabolite yeselula emaphakathi kanye ne-coenzyme ehilelekile ekuphenduleni kwamakhemikhali amaningi e-biochemical, edlala indima ebalulekile ekulawuleni ukuguqulwa kwamaselula kanye ne-homeostasis yamandla. Amazinga e-NAD+ ehla ngokuguga kanye nakweminye iminyaka yobudala{4}izifo ezihlobene, futhi lokhu kwehliswa kuhlotshaniswa nezimpawu eziningi zokuguga, okuhlanganisa ukungasebenzi kahle kwe-mitochondrial, ukungazinzi kwe-genomic, kanye nokuxhumana kwamaselula okushintshile.I-Liposomal NAD+ powderibhekana nemikhawulo ye-bioavailability yokwakheka kwe-NAD+ okuvamile ngokusebenzisa i-phospholipid encapsulation, okuvumela amabhrendi ukuthi athuthukise imikhiqizo-esekelwe isayensi esekela amandla eselula nezindlela ezinempilo zokuguga.

 

 

 

I-NAD+ yatholwa eminyakeni eyikhulu edlule, nokho ukubaluleka kwayo okugcwele kwebhayoloji kuyaqhubeka nokuvela. I-NAD+ iyi-metabolite yeselula ebalulekile ehilelekile ekuphenduleni kwamakhemikhali amaningi e-biochemical, okuhlanganisa ukulawulwa kwe-metabolic metabolism, ukukhiqizwa kwamandla, ukulungiswa kwe-DNA, i-mitophagy kanye ne-autophagy, ukuvuvukala, nokusebenza kwe-neuronal. I-NAD+ isebenza umsebenzi ombaxambili, isebenza kokubili njenge-cofactor ku-metabolism nanjengomlamuleli ekusayineni kwamaselula, okuyenza ibe semqoka ekugcineni i-homeostasis yamaselula, ukukhula, nokusinda.

I-NAD+ ikhona ngamafomu amabili-i-oxidized (NAD+) kanye nencishisiwe (NADH){3}}eguqukayo ekuphenduleni kwe-redox. Lokhu kuguqulwa kuyisisekelo ekukhiqizeni amandla eselula. I-intracellular NAD+/NADH ratio isiza ukulawula ukugeleza kwe-metabolic futhi ibe nomthelela ekusebenzeni kahle kokukhiqizwa kwe-ATP ye-mitochondrial. I-NADH, uhlobo oluncishisiwe lwe-NAD+, isebenza njengomnikeli we-electron oyinhloko ochungechungeni lokuphefumula lwe-mitochondrial, olubandakanya ukukhiqizwa kwe-adenosine triphosphate nge-oxidative phosphorylation. Konjiniyela bezengezo, lobu budlelwano buchaza ukuthi kungani ukutholakala kwe-NAD+ kuxhumene kakhulu ne-mitochondrial energy metabolism kanye nocwaningo lokusebenza kwamaselula.

Ngalé kwendima yayo eyisisekelo njenge-redox coenzyme kumetabolism yamandla, i-NAD+ isebenza njenge-co-i-substrate ebalulekile yezigaba ezintathu eziyinhloko zama-enzyme okusayina: i-sirtuin deacylases, i-ADP-i-ribose transferases (okuhlanganisa nama-PARP), kanye ne-cyclic ADP-ribose synthases. Lokhu kubeka i-NAD+ njengendawo emaphakathi ye-metabolic elawula ngokuhlelekile yonke inethiwekhi yezempilo yamaselula nokuguga.

 

 

I-NAD+/NADH Redox Cycle

Umsebenzi oyinhloko we-bioenergetic we-mitochondria ukukhiqiza i-adenosine triphosphate (ATP) kusukela ekuqhekekeni kwezakhi ngokusebenzisa i-oxidative phosphorylation. I-NAD+ idlala indima ebalulekile kule nqubo. Ngesikhathi sokusabela kwe-catabolic-okuhlanganisa i-glycolysis ku-cytoplasm kanye nomjikelezo we-tricarboxylic acid (TCA) ku-mitochondria{4}}I-NAD+ yamukela ama-electron, okwenza i-NADH.

I-NADH ekhiqizwayo ibe isivalelwa ku-mitochondrion, iletha-ama-electron anamandla aphezulu kuma-protein complexes ochungechungeni lwezokuthutha lwama-electron. Njengoba ama-electron egeleza kulezi zinkimbinkimbi, ama-proton ampontshelwa kulwelwesi lwangaphakathi lwe-mitochondrial, enze i-electrochemical gradient eshayela i-ATP synthase ukuze ikhiqize i-ATP.

I-NAD+ njengenzwa Yamandla

I-NAD(H) ingasebenza njengenzwa yamandla exhumanisa ukutholakala komsoco, isimo samandla eselula, nokukhiqizwa kwe-ATP. I-intracellular NAD+/NADH ratio iyinkomba eyinhloko yesimo se-metabolic. Uma amazinga e-NAD+ anele, amaseli akhiqiza i-ATP ngempumelelo nge-oxidative phosphorylation. Ngesikhathi sokuncipha kwe-NAD+, amaseli avame ukushintshela ku-anaerobic glycolysis, ehlisa ukusebenza kahle kokukhiqizwa kwe-ATP nokwandisa ukukhiqizwa kwe-lactate.

I-NAD+ iphinde iguqule ibhalansi phakathi kwe-glycolysis kanye ne-oxidative phosphorylation, ibe nomthelela ekuguquguqukeni kwe-metabolic kwamaseli. Le ndima yokulawula ihambisana ikakhulukazi nezicubu ezidinga amandla aphezulu, njengobuchopho, inhliziyo, nemisipha yamathambo. I-NAD+ ne-NADH idlala indima ebalulekile ekuhlanganiseni kwe-ATP nasekulawuleni amandla e-metabolic ebuchosheni futhi ibalulekile ezinqubweni ze-metabolic ezifana ne-glycolysis, i-ketolysis, -i-oxidation, nomjikelezo we-TCA.

 

 

I-PARP1 Activation kanye ne-NAD+ Ukusetshenziswa

Lapho kwenzeka umonakalo we-DNA, iseli lifaka impendulo esheshayo. I-PARP1 (i-poly ADP-i-ribose polymerase 1) ingelinye lamaprotheni okuqala ukuzwa nokubopha i-DNA eyonakele. Lapho ibophezela kumakhefu e-DNA, i-PARP1 iqala ukusebenza futhi isebenzisa i-NAD+ njenge-substrate. I-PARP1 ihlukanisa i-NAD+ futhi idlulisele umphumela we-ADP{10}}we-ribose moiety kumaprotheni aqondiwe, inqubo eyaziwa ngokuthi i-poly(ADP{11}}ribosyl)ation (PARylation).

Lo mcimbi we-PARylation wenza imisebenzi eminingi: unxenxa amanye amaprotheni okulungisa i-DNA endaweni yomonakalo, ulungisa ukwakheka kwe-chromatin ukuze kube lula ukufinyelela ku-DNA eyonakele, futhi ubonisa ukuthi iseli liyalungiswa. I-axis ye-NAD+–PARP1–XRCC1 ihlezi empambanweni yokugcinwa kofuzo nokulawulwa kwe-metabolic, exhumanisa ukubonakaliswa komonakalo we-DNA ku-bioenergetics yamaselula.

 

Izindleko ze-NAD+ Zokulungisa I-DNA

I-PARP1 iwumsebenzi omkhulu odla i-NAD+-ku-nucleus futhi idlala indima ebalulekile ekugcineni ubuqotho be-genomic. Umsebenzi obanzi wokulungisa i-DNA ungadla amanani abalulekile e-NAD+. Uma umonakalo we-DNA mkhulu{4}}njengoba kwenzeka ngokuguga, ukucindezeleka kwendawo, noma ukuvuvukala{5}}I-PARP1 hyperactivation ingaqeda izinqolobane ze-NAD+ zamaselula.

Lokhu kudala inselele ye-bioenergetic: iseli kufanele lilinganise isidingo esisheshayo sokulungiswa kwe-DNA ngokumelene nezindleko ze-metabolic zokusetshenziswa kwe-NAD+. I-PARP1 hyperactivation kanye nokuncipha kwe-NAD+ kuye kwathinteka ezimeni ezihlukahlukene zeminyaka-ehlobene. Ukuqonda lobu budlelwano kubalulekile kubadidiyeli abakha imikhiqizo esekela impilo yamaselula. Ngakho-ke i-NAD+ metabolism iyindawo enentshisekelo yesayensi ekuqondeni izimpendulo zamaselula emonakalweni we-DNA nokuguga.

 

 

I-NAD+ Njengenani-I-Substrate Ekhawulayo

I-Sirtuins (SIRT1–SIRT7) iwumndeni wama-NAD{2}}ama-dependent deacetylase adlala indima ebalulekile esikhathini sempilo kanye{3}}nezifo ezihlobene neminyaka. I-NAD+ iyi-cofactor ebalulekile elawula i-homeostasis ye-metabolic kanye nenani-elikhawulela i-substrate yama-sirtuin deacylases. Ngoba amazinga e-NAD+ yeselula ayakhawulela umsebenzi we-sirtuin, ukutholakala kwe-NAD+ kuthonya ngokuqondile ukusebenza kwe-sirtuin.

Ama-Sirtuins ahlanganisa izinqubo ze-metabolic kanye nengcindezi-ezisabelayo. I-SIRT3, i-sirtuin ye-mitochondrial, isusa amaqembu e-acetyl futhi ithuthukise umsebenzi wama-enzyme abalulekile abamba iqhaza ekuqhekekeni kwe-fatty acid, umjikelezo we-TCA, kanye neketango lokuthutha i-electron, ngaleyo ndlela kuthuthukiswe ukusebenza kahle kwe-mitochondrial nokukhiqizwa kwamandla.

I-Sirtuins kanye nocwaningo lokuguga olunempilo

Amazinga e-NAD+ ancishiswa ezinto eziphilayo esezikhulile, futhi izifundo kumamodeli ezinto eziphilayo ziphakamisa ukuthi ukubuyisela ukutholakala kwe-NAD+ kungase kuthonye{2}}izinguquko ezihlobene nobudala ezihambisana nempilo ende{3}}ezindleleni ezihlobene. Kumamodeli ezilwane, amasu okubuyisela e-NAD+ asephenyiwe ngemiphumela yawo engaba khona eminyakeni-ehlobene nezinguquko ze-metabolic. Indlela ye-NAD+/sirtuin iye yafundelwa indima yayo ekulungiseni ukuphila isikhathi eside ngokusebenzisa i-mitochondrial UPR (impendulo engavuliwe yamaprotheni) kanye nokusayina kwe-FOXO. Ukuncipha kwe-NAD+ kuthinta izimpawu eziningi zokuguga, okwenza i-NAD+ metabolism ibe ithagethi yentshisekelo ebalulekile yesayensi. I-Sirtuins, umndeni wama-enzyme ancike ku-NAD{13}, idlala indima ebalulekile ekuhlanganiseni izinqubo ze-metabolic kanye nengcindezi{14}}ezisabelayo. I-NAD+ metabolism, i-subcellular compartmentalisation, kanye nemisebenzi ethile ye-sirtuin iyahlangana ukuze yakhe inethiwekhi edidiyelwe yokulawula elawula i-homeostasis ye-metabolic.

 

 

I-Bioavailability Barrier

Naphezu kwendima eyinhloko ye-NAD+ empilweni yamaselula, izithako ezivamile zomlomo ze-NAD+ zibhekana nemikhawulo eyisisekelo. I-NAD+ inesisindo samangqamuzana esikhulu (663.43 Da) kanye nesakhiwo esiyinkimbinkimbi esinikela ekungeneni kolwelwesi olulinganiselwe. I-NAD+ futhi ayizinzile ngokwangaphakathi, yehlisa isithunzi kalula emazingeni okushisa akhona noma aphakeme, akhawulela ukusetshenziswa kwayo kumaphilisi namaphilisi ajwayelekile.

Isebenza kanjani i-Liposomal Encapsulation

Ubuchwepheshe bokulethwa kwe-Liposomal bubhekana nalezi zinselele ngokusebenzisa i-phospholipid encapsulation. Ama-molecule e-NAD+ ambozwe ngaphakathi kwama-bilayers e-phospholipid{2}}ngokuvamile atholakala ku-sunflower okungeyona-i-GMO noma i-lecithin ye-soy{4}okwakha ama-microscopic vesicles ngokuvamile phakathi kwebanga le-nanoscale.

Indlela	Incazelo
Ukuvikelwa ngesikhathi sokuhamba kwamathumbu	I-phospholipid bilayer ivikela i-NAD+ ekuwohlokeni komgudu wokugaya ukudla, iwuvikele ku-asidi yesisu kanye nama-enzyme okugaya ukudla.
Ukuthatha amaselula okuthuthukisiwe	Ngenxa yokuthi ukwakheka kwe-lipid kufana nolwelwesi lwamaseli lwemvelo, ama-liposomes angase ahlanganyele nolwelwesi lwamathumbu ngokusebenzisa izindlela ezihlanganisa ukuhlanganiswa kwe-membrane kanye ne-endocytosis.
Kwehliswe{0}}i-pass metabolism yokuqala	Isakhiwo se-liposomal singase sinciphise izinga-lokudlula kwemetabolism, okungase kuvumele ingxenye enkulu yama-molecule e-NAD+ angaguquki ukuthi afinyelele ukujikeleza kwesistimu.

Ubufakazi Besayensi

Ucwaningo olungelona-okungahleliwe lwe-crossover olushicilelwe ngo-2026 lwaphenya imiphumela ye-oral liposomal NAD+ supplementation kumazinga we-intracellular NAD+ kubantu. Abahlanganyeli abayishumi nane bathathe i-1,000 mg ye-liposomal NAD+ nsuku zonke amasonto amabili. Ngemuva kwezinsuku eziyi-14, ababambiqhaza babike ukukhuphuka okujwayelekile okungaphezulu kwe-64% kumazinga we-intracellular NAD+ uma kuqhathaniswa nesisekelo. Lolu cwaningo luhlinzeka ngobufakazi bokuqala bomuntu obuphakamisa ukuthi ukwengezwa kwe-liposomal NAD+ yomlomo kungase kwenyuse amazinga e-intracellular NAD+. Nakuba kukhuthaza, izinhlolo ezinkulu ezilawulwa ngokungahleliwe ziyadingeka ukuze kuqinisekiswe lokhu okutholakele.

 

 

 

Okwemikhiqizo ethuthukayoI-liposomal NAD + supplements, izinzuzo zezentengiso zidlulela ngale kwesayensi:

Zuza	Umthelela Wezentengiselwano
Ukuhlukaniswa komkhiqizo	Ukulethwa kwe-Liposomal kunika amandla isikhundla se-premium emakethe ekhulayo yokuphila isikhathi eside
Ukwakheka okuguquguqukayo	Itholakala ngamafomethi amaningi-amaphilisi, izimpushana, iziphuzo
Ukuxhumana okusebenzayo	Idatha ye-Pharmacokinetic inikeza isisekelo esithembekile sokumaketha kobuchwepheshe
Ukwesekwa ngokokulawula	Imibhalo ephelele yenza kube lula ukufinyelela emakethe

Okokuthola abakhiqiziinqwaba ye-liposomal NAD+ powder, ukukhetha umphakeli wesithako we-NAD+ onolwazi kudinga ukuhlolwa ngokucophelela kwamakhono okukhiqiza, idatha ye-encapsulation esebenza kahle, ukuvumelana kosayizi wezinhlayiyana, kanye nezitifiketi zekhwalithi.

 

 

I-Liposomal NAD+ imele intuthuko ethembisayo ekwengezeni kwezempilo kwamaselula, kubhekwana nemikhawulo ye-bioavailability ebikade ivimbela ukwakheka okujwayelekile kwe-NAD+. Ngokufaka i-phospholipid encapsulation, ubuchwepheshe buvikela i-NAD+ ekonakalisweni kwamathumbu futhi kusiza ukutholwa kwamaselula, okwenza i-coenzyme ikwazi ukusekela imisebenzi yayo emithathu eyinhloko yamaselula: ukukhiqizwa kwe-ATP ngomjikelezo we-NAD+/NADH redox, ukulungiswa kwe-DNA ngendlela ye-PARP1, nokuguga okunempilo ngokusebenzisa i-sirtuin activation.

Kubathengi be-B2B-abadidiyeli, abaqondisi be-R&D, abaphathi bokuthengwa kwempahla, nabanikazi bomkhiqizo{2}}lokhu kuhumushela ezinzuzweni ezibambekayo zezentengiselwano: amaphothifoliyo omkhiqizo ahlukene, isayensi{3}}ukuthuthukiswa kokubunjwa okunolwazi, ukuma kwemakethe ye-premium, nobudlelwano obuthembekile bochungechunge lokuhlinzeka. Emkhakheni wemakethe okhulayo, i-liposomal NAD+ inika amandla amabhrendi ukuthi alethe lokho okulindelwe ngabathengi ukuze kube nobufakazi{{6}obusekelwe, izithako ezinempilo ezitholakalayo zokuguga ngenkathi yakhela inzuzo yokuncintisana.

 

Ingabe usukulungele ukuthuthukisa ukwakheka kwakho kwe-premium liposomal NAD+?Ithimba lethu lobuchwepheshe liyatholakala ukuze lisekele ukuthuthukiswa komkhiqizo wakho kusukela kumqondo kuya ekuqalisweni kwezentengiso. Ochwepheshe bethu bokwenza izinto bangasiza ekukhetheni isithako, ukuthuthukiswa kokwakheka, ukuhlolwa kokuhlola, amaphrojekthi we-OEM/ODM, kanye nemibhalo yokulawula yezimakethe zamazwe ngamazwe.

• Cela isampulaokokuhlola{0}kwasendlini kanye nezivivinyo zokwakha
• Cela iphakethe lamadokhumenti obuchwepheshe(COA, izifundo zokuzinza, ukuhlaziywa kosayizi wezinhlayiyana)
• Buza mayelana nokucaciswa ngokwezifiso(ukugxila, usayizi wezinhlayiya, izinketho ze-excipient)
• Hlela ukubonisana kwezobuchwepheshenososayensi bethu bokwakha

Xhumana nethimba lethu le-B2B namuhla ukuze uxoxe ngezidingo zakho zokuthola usizo. I-imeyili:liu@wellgreenxa.com

 

 

1. Lautrup S, et al. Izindima ze-NAD+ Kwezempilo Nokuguga.Cold Spring Harb Perspect Med. 2024;14(1):a041193. doi:10.1101/cshperspect.a041193
2. Migaud ME, et al. Ukulawulwa kanye nezinselelo ekuqondisweni kwe-NAD+ metabolism.I-Nat Rev Mol Cell Biol. 2024;25(10):822-840. doi:10.1038/s41580-024-00752-w
3. Iqhaza Elibalulekile le-NAD+ ku-Mitochondrial Metabolic Regulation.I-Biocell. 2025;49(7):1101-1123.
4. I-NAD (H) ekudluliselweni kwamandla e-mitochondrial: imiphumela yezempilo nezifo.IsayensiDirect. 2018.
5. Imininingwane ye-molecular ekusebenzeni kwe-PARP1: structural dynamics of DNA, NAD+, kanye ne-zinc-mediated allosteric regulation.I-PubMed. 2025.
6. I-NAD+/Sirtuin Pathway Imodula Ukuphila Okude Ngokusebenzisa I-Mitochondrial UPR kanye Nokusayina kwe-FOXO.I-PubMed. 2013.
7. Inethiwekhi ye-Sirtuin: Ukuxhumanisa i-NAD+ Metabolism, Umsebenzi we-Mitochondrial, kanye ne-Metabolic Homeostasis.Umfundisi we-Diabetes Metab Res. 2026. doi:10.1002/dmrr.70201
8. U-Blair E, u-Miller A, uMcDonald R. Ukhushulwe Amazinga e-Intracellular NAD+ Nge-Oral Supplementation With a Novel Liposomal Delivery Method: A Non{2}}Non{2}}I-Randomized Crossover Study.I-NDNR. 2026.